JP2026004279A5 - - Google Patents
Info
- Publication number
- JP2026004279A5 JP2026004279A5 JP2025138126A JP2025138126A JP2026004279A5 JP 2026004279 A5 JP2026004279 A5 JP 2026004279A5 JP 2025138126 A JP2025138126 A JP 2025138126A JP 2025138126 A JP2025138126 A JP 2025138126A JP 2026004279 A5 JP2026004279 A5 JP 2026004279A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908305P | 2019-09-30 | 2019-09-30 | |
| US62/908,305 | 2019-09-30 | ||
| JP2022519458A JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
| PCT/US2020/053258 WO2021067261A1 (en) | 2019-09-30 | 2020-09-29 | Knottin-immunostimulant conjugates and related compositions and methods |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Division JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026004279A JP2026004279A (ja) | 2026-01-14 |
| JP2026004279A5 true JP2026004279A5 (https=) | 2026-01-21 |
Family
ID=75337493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Pending JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
| JP2025138126A Pending JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Pending JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220257785A1 (https=) |
| EP (1) | EP4037709A4 (https=) |
| JP (2) | JP2022549915A (https=) |
| KR (1) | KR20220071225A (https=) |
| CN (1) | CN114585382A (https=) |
| AU (1) | AU2020357806A1 (https=) |
| CA (1) | CA3156165A1 (https=) |
| WO (1) | WO2021067261A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| US12414997B2 (en) | 2018-04-13 | 2025-09-16 | Massachusetts Institute Of Technology | Brush prodrugs and uses thereof |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| JP2022533671A (ja) * | 2019-05-22 | 2022-07-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 薬物複合体およびその使用方法 |
| EP4045562A2 (en) * | 2019-10-16 | 2022-08-24 | Massachusetts Institute of Technology | Brush prodrugs and uses thereof |
| WO2025103490A1 (en) * | 2023-11-16 | 2025-05-22 | Beijing Changping Laboratory | N-oxide immune agonists activation by radiotherapy |
| WO2025193946A2 (en) * | 2024-03-14 | 2025-09-18 | Genentech, Inc. | Peptides binding lrrc15 and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10844106B2 (en) * | 2010-11-08 | 2020-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| US9587001B2 (en) * | 2012-10-19 | 2017-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugated knottin mini-proteins containing non-natural amino acids |
| WO2014201245A1 (en) * | 2013-06-12 | 2014-12-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors |
| CA2957717C (en) * | 2014-08-12 | 2021-10-19 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein |
| US10888603B2 (en) * | 2016-02-12 | 2021-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cancer cells expressing tumor-associated integrins |
| US10765625B2 (en) * | 2016-03-15 | 2020-09-08 | The Board Of Trustees Of The Leland Stanford Junior University | Knottin-drug conjugates and methods of using the same |
| MX2019012295A (es) * | 2017-04-14 | 2020-02-07 | Tollnine Inc | Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso. |
| JP2022533671A (ja) * | 2019-05-22 | 2022-07-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 薬物複合体およびその使用方法 |
| WO2022026906A2 (en) * | 2020-07-30 | 2022-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Lysosomal targeting molecules comprising knottin peptides and related compositions and methods |
-
2020
- 2020-09-29 AU AU2020357806A patent/AU2020357806A1/en active Pending
- 2020-09-29 CA CA3156165A patent/CA3156165A1/en active Pending
- 2020-09-29 EP EP20870659.8A patent/EP4037709A4/en active Pending
- 2020-09-29 KR KR1020227013406A patent/KR20220071225A/ko active Pending
- 2020-09-29 WO PCT/US2020/053258 patent/WO2021067261A1/en not_active Ceased
- 2020-09-29 JP JP2022519458A patent/JP2022549915A/ja active Pending
- 2020-09-29 US US17/762,694 patent/US20220257785A1/en active Pending
- 2020-09-29 CN CN202080072773.4A patent/CN114585382A/zh active Pending
-
2025
- 2025-08-21 JP JP2025138126A patent/JP2026004279A/ja active Pending